Postmarketing Surveillance Study of XGEVA (Denosumab) in South Korea (20160198)

First published 17/04/2017

Last updated 22/04/2021

EU PAS number:

EUPAS18114

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

01.20.01 Protocol Ver 1.0 2016-08-29 redacted final

English (483.34 KB - PDF)View document

Study results

Study results

Denosumab_20160198_Study_Report_Abstract_Observational_Final_Analysis_Redacted (3)

English (228.01 KB - PDF)View document

Study report

Other information